The interleukin-23 receptor pairs with the interleukin-12 receptor β-1 subunit to mediate signalling of interleukin-23, a “master regulator” of innate and adaptive immunity and promoter of inflammatory mediators in the tumour microenvironment.117. This evidence concerns the gene IL37 and neoplasm.